RecallDepth
Class II Ongoing

Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-467-06

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
May 13, 2024
Posted
June 12, 2024
Recall Number
D-0534-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2400 cartons
Firm Location
Mahwah, NJ, United States

Reason for Recall

CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

Distribution

US Nationwide.

Lot / Code Info

Lot#: 19224857; Exp. 11/2024 Lot#: 19232493; Exp. 6/2025

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls